Abstract：
Species of genus Morus (family Moraceae) have been used as traditional medicinal and edible resources since ancient times. Genus Morus has been acknowledged as a promising resource for the exploration of novel compounds with various bioactivities. Phytochemical investigations of the genus have led to the discovery of more than approximately 453 natural products from 2011 to 2023, mainly including flavonoids, Diels-Alder adducts, 2-arylbenzfuran, alkaloids and stilbenes. Bioactive constituents and extracts of this genus displayed a wide range of impressive biological properties including antidiabetic, anti-inflammatory, antioxidant, anti-cancer, hepatoprotective, renoprotective, and some other activities. Herein, the research progress of this genus Morus from 2011 to 2023 on phytochemistry and pharmacology are systematically presented and discussed for the first time. This current review provides the easiest access to the information on genus Morus for readers and researchers in view of enhancing the continuity on research done on this genus.
摘要：
桑属植物（桑科）自古以来就被用作传统的药用和可食用资源。桑属已被认为是探索具有各种生物活性的新型化合物的有希望的资源。从2011年到2023年，对该属的植物化学研究导致发现了大约453种天然产物，主要包括类黄酮，Diels-Alder加合物,2-芳基苯并呋喃,生物碱和二苯乙烯。该属的生物活性成分和提取物显示出广泛的令人印象深刻的生物学特性，包括抗糖尿病，抗炎,抗氧化剂，抗癌，保肝,保护肾脏,和其他一些活动。在这里，系统介绍了该属植物2011-2023年在植物化学和药理方面的研究进展，并进行了讨论。鉴于增强对该属研究的连续性，当前的评论为读者和研究人员提供了有关桑属属的信息的最简单访问。
